U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...

For many, the high cost of the injection means stopping is a matter of 'when,' not 'if.' Endocrinologists reveal the crucial ...

The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.

Recently, the United States has witnessed an intense legal and commercial confrontation between major pharmaceutical ...

Obesity medications, once facing shortages, are now widely available. So how do consumers not get scammed into purchasing ...

DoseSpot, which delivers best-in-class e-prescribing, insurance verification and revenue cycle management solutions for healthcare providers, announced today the results of a new data analysis on 102, ...

Cruise ships aren’t usually associated with optimal health. If anything, they’ve earned a bad reputation through news cycles ...

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

Stocks that pay dividends tend to outperform ones that don't. Consensus price targets for Novo Nordisk suggest the stock can ...

If there's one thing blue-state liberals and Trump populists can agree on, it's that pharmaceutical firms charge too much for their drugs. That core belief has propelled Connecticut to the leading ...